Visual Assessment and Dermoscopy Enhanced by Non-invasive Genomic Testing
Main Article Content
Keywords
Genomics, Dermoscopy, Visual assessment, Melanoma
References
2. Dinnes J, Deeks JJ, Chuchu N, et al. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults. Cochrane Database Sys Rev.2018;12(12):Cd011902.
3. Wolner ZJ, Yelamos O, Liopyris K, Rogers T, Marchetti MA, Marghoob AA. Enhancing skin cancer diagnosis with dermoscopy. Dermatol Clin. 2017;35(4);417-437.
4. Argenziano G, Kittler H, Ferrara G, et al. Slow-growing melanoma: a dermoscopy follow-up study. Br J Dermatol.2010;162(2):267-273.
5. Lallas A, Longo C, Manfredini M, et al. Accuracy of dermoscopic criteria for the diagnosis of melanoma in situ. JAMA Dermatol.2018;154(4):414-419.
6. Rose SE, Argenziano G, Marghoob AA. Melanomas difficult to diagnose via dermoscopy. G Ital Dermatol Venereol.2010;145(1):111-126.
7. Gerami P, Yao Z, Polsky D, et al. Development and validation of noninvasive 2-gene molecule assay for cutaneous melanoma. J Am AcadDermatol. 2017;76(1):114-120.e112.
8. Skelsey MK, Rock J, Howell MD, et al. Non-invasive detection of genomic atypia increases real-world NPV and PPV of the melanoma diagnostic pathway and reduces biopsy burden. Skin. 2021;5(5):512-523.
9. Jackson SR, Jansen, B, Yao Z, et al. Risk stratification of severely dysplastic nevi by non-invasively obtained gene expression and mutation analysis. Skin.2020;4(2):105-110.
10. Markowitz O. A Practical Guide to Dermoscopy. Wolters Kluwer; 2017:9-23.
11. Ferris LK, Jansen B, Ho J, et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect of the decision to biopsy. JAMA Dermatol.2017;153(7):672-680.
12. Ianosi SL, Calbureanu-Popescu MX, Ianosi NG, et al. The importance of dermoscopy in early recognition of melanoma in situ. Curr Health Sci J. 2019;45(4):366-371.
13. Petty AJ, Ackerson B, Garza R, et al. Meta-analysis of number needed to treat diagnosis of melanoma by clinical setting. J Am AcadDermatol. 2020;82(5):1158-1165.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.